Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions: Intestinal Research Online
Harris A. Ahmad, James E. East, Remo Panaccione, Simon Travis, James B. Canavan, Keith Usiskin, Michael F. Byrne
Artificial intelligence represents a new era within the field of gastroenterology, and the amount of research surrounding artificial intelligence in patients with inflammatory bowel disease is on the rise.
Satisfai Health CEO & Founder Dr. Michael Byrne shares, “Further to our recent paper on AI in Clinical Trials for IBD, another review from our group has just been published on how Artificial Intelligence solutions are coming for the management of Inflammatory Bowel Disease in Clinical Practice and Future Directions.”
The purpose of this review is to provide an overview of the unmet needs in the management of inflammatory bowel disease in clinical practice and how artificial intelligence tools can address these gaps to transform patient care.
